Impact of mutations in blood cancer-related genes on clinical outcomes in chronic myeloid leukemia in chronic phase (CML-CP) after ≥2 tyrosine kinase inhibitors ( TKIs) in the Ascembl trial Meeting Abstract
| Authors: | Branford, S.; Hochhaus, A.; Mauro, M.; Minami, Y.; Rea, D.; Freitas, Cmbd; Serrano-Fernandez, P.; Obourn, V.; Bruederle, A.; Espurz, N.; Hughes, T. P. |
| Abstract Title: | Impact of mutations in blood cancer-related genes on clinical outcomes in chronic myeloid leukemia in chronic phase (CML-CP) after ≥2 tyrosine kinase inhibitors ( TKIs) in the Ascembl trial |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 449 |
| Language: | English |
| ACCESSION: | WOS:001159306701206 |
| DOI: | 10.1182/blood-2023-187636 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
